OptimizeRx Newsroom

OptimizeRx Price Target Cut to $5.00/Share From $11.00 by Barclays

Dow JonesNov 14 22:15

Stifel Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $8

Futu NewsNov 14 21:34

Roth MKM Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $16

Futu NewsNov 14 21:34

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Ontrak (OTRK) and Ayr Wellness (OtherAYRWF)

TipRanksNov 14 21:12

OptimizeRx Is Maintained at Market Outperform by JMP Securities

Dow JonesNov 14 20:42

OptimizeRx Analyst Ratings

BenzingaNov 14 20:32

RBC Capital Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $7

Futu NewsNov 14 20:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (PTCT), Medtronic (MDT) and OptimizeRx (OPRX)

TipRanksNov 14 17:53

Barclays Sticks to Their Hold Rating for OptimizeRx (OPRX)

TipRanksNov 14 17:53

JMP Securities Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $8

Futu NewsNov 14 13:31

OptimizeRx: Buy Rating Affirmed Amid Financial Efficiency and Business Model Shift

TipRanksNov 14 13:27

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 13 22:32

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 12 22:31

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 11 22:33

OptimizeRx (OPRX) Receives a Buy From Lake Street

TipRanksNov 11 22:00

JMP Securities Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 11 02:31

Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsSep 10 21:32

RBC Capital Maintains Outperform on OptimizeRx, Lowers Price Target to $14

BenzingaAug 16 23:27

OptimizeRx Analyst Ratings

BenzingaAug 16 23:25

RBC Capital Maintains OptimizeRx(OPRX.US) With Buy Rating, Cuts Target Price to $14

Futu NewsAug 16 19:34